ISBN: 9781617373961 - molecular diagnosis of cancer: methods and protocols: 97 (18 risultati)

Condizione: New.

Condizione: New.

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Condizione: New. Editor(s): Roulston, Joseph E.; Bartlett, John M. S. Series: Methods in Molecular Medicine. Num Pages: 394 pages, biography. BIC Classification: MMF. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 21. Weight in Grams: 544. . 2010. 2nd ed. Softcover of orig. ed. 2004. Paperback. . . . . …

Condizione: As New. Unread book in perfect condition.

Condizione: New. pp. 408.

Taschenbuch. Condizione: Neu. Molecular Diagnosis of Cancer | Methods and Protocols | Joseph E. Roulston (u. a.) | Taschenbuch | Methods in Molecular Medicine | xii | Englisch | 2010 | Humana | EAN 9781617373961 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Paperback. Condizione: Brand New. 2nd edition. 408 pages. 9.25x6.10x0.92 inches. In Stock.

Condizione: New. Editor(s): Roulston, Joseph E.; Bartlett, John M. S. Series: Methods in Molecular Medicine. Num Pages: 394 pages, biography. BIC Classification: MMF. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 21. Weight in Grams: 544. . 2010. 2nd ed. Softcover of orig. ed. 2004. Paperback. . . . . Books ship from the US and Ireland. …

Condizione: New. In English.

Condizione: new. Questo è un articolo print on demand.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -We are currently experiencing a fundamental shift in the way in which we approach the characterization of cancer. Never before has the make up of cancer tissues and individual cells been so exhaustively researched and char- terized. We are now capable of producing molecular 'fingerprints' that ch- acterize the expression of all known and unknown genes within tumors and their surrounding tissues. More than 30,000 different genes may be measured in each patient's tumor in a single experiment. Simultaneously, novel therapies that exploit the molecular roadmap have been developed and are now being offered to patients. These novel agents, such as Glivec, Herceptin, Iressa, and others, specifically target individual genes within tumors and can produce d- matic responses in some patients. These drugs are only the forerunners of a coming tidal wave of novel therapeutics that individually target specific m- ecules within cancer cells-more than 300 such agents are currently in phase I or II clinical trials. This is an exciting time for cancer specialists and patients alike. However, if we have learned anything from the past 50 or more years of research into cancer, it is that Lord Beaverbrook, in founding the British national health service in the 1950s, was frighteningly prescient when he defined the primary goal of health care to be 'Diagnosis, Diagnosis, Diag- sis. ' Now, more than ever, it is essential that appropriate diagnostic methods and approaches are applied to the selection of patients for treatment. 408 pp. Englisch.…

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. We are currently experiencing a fundamental shift in the way in which we approach the characterization of cancer. Never before has the make up of cancer tissues and individual cells been so exhaustively researched and char- terized. We are now capable of pr.…

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - We are currently experiencing a fundamental shift in the way in which we approach the characterization of cancer. Never before has the make up of cancer tissues and individual cells been so exhaustively researched and char- terized. We are now capable of producing molecular 'fingerprints' that ch- acterize the expression of all known and unknown genes within tumors and their surrounding tissues. More than 30,000 different genes may be measured in each patient's tumor in a single experiment. Simultaneously, novel therapies that exploit the molecular roadmap have been developed and are now being offered to patients. These novel agents, such as Glivec, Herceptin, Iressa, and others, specifically target individual genes within tumors and can produce d- matic responses in some patients. These drugs are only the forerunners of a coming tidal wave of novel therapeutics that individually target specific m- ecules within cancer cells-more than 300 such agents are currently in phase I or II clinical trials. This is an exciting time for cancer specialists and patients alike. However, if we have learned anything from the past 50 or more years of research into cancer, it is that Lord Beaverbrook, in founding the British national health service in the 1950s, was frighteningly prescient when he defined the primary goal of health care to be 'Diagnosis, Diagnosis, Diag- sis. ' Now, more than ever, it is essential that appropriate diagnostic methods and approaches are applied to the selection of patients for treatment.…

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -We are currently experiencing a fundamental shift in the way in which we approach the characterization of cancer. Never before has the make up of cancer tissues and individual cells been so exhaustively researched and char- terized. We are now capable of producing molecular ¿fingerprints¿ that ch- acterize the expression of all known and unknown genes within tumors and their surrounding tissues. More than 30,000 different genes may be measured in each patient¿s tumor in a single experiment. Simultaneously, novel therapies that exploit the molecular roadmap have been developed and are now being offered to patients. These novel agents, such as Glivec, Herceptin, Iressa, and others, specifically target individual genes within tumors and can produce d- matic responses in some patients. These drugs are only the forerunners of a coming tidal wave of novel therapeutics that individually target specific m- ecules within cancer cells¿more than 300 such agents are currently in phase I or II clinical trials. This is an exciting time for cancer specialists and patients alike. However, if we have learned anything from the past 50 or more years of research into cancer, it is that Lord Beaverbrook, in founding the British national health service in the 1950s, was frighteningly prescient when he defined the primary goal of health care to be ¿Diagnosis, Diagnosis, Diag- sis. ¿ Now, more than ever, it is essential that appropriate diagnostic methods and approaches are applied to the selection of patients for treatment.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 408 pp. Englisch.…

Condizione: New. Print on Demand pp. 408 60 Illus.

Condizione: New. PRINT ON DEMAND pp. 408.